Abstract
Summary
Green tea polyphenols (GTP) are promising agents for preventing bone loss. GTP supplementation sustained microarchitecture and improved bone quality via a decrease in inflammation. Findings suggest a significant role for GTP in skeletal health of patients with chronic inflammation.
Introduction
This study evaluated whether GTP can restore bone microstructure along with a molecular mechanism in rats with chronic inflammation. A 2 [placebo vs. lipopolysaccharide (LPS)]× 2 [no GTP vs. 0.5% GTP (w/v) in drinking water] factorial design was employed.
Methods
Female rats were assigned to four groups: placebo, LPS, placebo + GTP, and LPS + GTP for 12 weeks. Efficacy was evaluated by examining changes in bone microarchitecture using histomorphometric and microcomputed tomographic analyses and by bone strength using the three-point bending test. A possible mechanism was studied by assessing the difference in tumor necrosis factor-α (TNF-α) expression in tibia using immunohistochemistry.
Results
LPS lowered trabecular volume fraction, thickness, and bone formation in proximal tibia while increasing osteoclast number and surface perimeter in proximal tibia and eroded surface in endocortical tibial shafts. GTP increased trabecular volume fraction and number in both femur and tibia and periosteal bone formation rate in tibial shafts while decreasing trabecular separation in proximal tibia and eroded surface in endocortical tibial shafts. There was an interaction between LPS and GTP in trabecular number, separation, bone formation, and osteoclast number in proximal tibia, and trabecular thickness and number in femur. GTP improved the strength of femur, while suppressing TNF-α expression in tibia.
Conclusion
In conclusion, GTP supplementation mitigated deterioration of bone microarchitecture and improved bone integrity in rats with chronic inflammation by suppressing bone erosion and modulating cancellous and endocortical bone compartments, resulting in a larger net bone volume. Such a protective role of GTP may be due to a suppression of TNF-α.
Similar content being viewed by others
References
Van Dyke TE, Serhan CN (2003) Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 82:82–90
Mann ST, Stracke H, Lange U, Klor HU, Teichmann J (2003) Alternations of bone mineral density and bone metabolism in patients with various grades of chronic pancreatitis. Metabolism 52:579–585
Bernstein CN, Leslie WD, Taback SP (2003) Bone density in a population-based cohort or premenopausal adult women with early onset inflammatory bowel disease. Am J Gastroenterol 98:1094–1100
Romas E, Gillespie MT, Martin TJ (2003) Involvement of receptor activator of NF-κB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 30:340–346
Uaratanawong S, Deesomchoke U, Lertmaharit S, Uaratanawong S (2003) Bone mineral density in premenopausal women with systemic lupus erythematosus. J Rheumatol 30(11):2365–2368
Banfi G, Iorio EL, Corsi MM (2008) Oxidative stress, free radicals and bone remodeling. Clin Chem Lab Med 46(11):1550–1555, Review
Miyaura C, Inada M, Matsumoto C, Ohshiba T, Uozumi N, Shimizu T, Ito A (2003) An essential role of cytosolic phospholipase A2 alpha in prostaglandin E2-mediated bone resorption associated with inflammation. J Exp Med 197(10):1303–1310
Cochran DL (2008) Inflammation and bone loss in periodontal disease. J Periodontol 79(8 Suppl):1569–1576
Boulos P, Ioannidis G, Adachi JD (2000) Glucocorticoid-induced osteoporosis. Curr Rheumatol Rep 2(1):53–61
Hofbauer LC, Brueck CC, Shanahan CM, Schoppet M, Dobnig H (2007) Vascular calcification and osteoporosis—from clinical observation towards molecular understanding. Osteoporos Int 18(3):251–259, Review
Mody N, Parhami F, Saraflan TA, Demer LL (2001) Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 31:509–519
Muthusami S, Ramachandran I, Muthusamy B, Vasudevan G, Prabhu V, Subramaniam V, Jagadeesan A, Narasimhan S (2005) Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats. Clin Chim Acta 360(1–2):81–86
Manolagas SC (2008) De-fense! De-fense! De-fense: scavenging H2O2 while making cholesterol. Endocrinology 149(7):3264–3266
Garrett JR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR (1990) Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 85:632–639
Shen CL, Yeh JK, Cao JJ, Tatum OL, Dagda RY, Wang JS (2009) Green tea polyphenols mitigate bone loss of female rats in a chronic inflammation-induced bone loss model. J Nutr Biochem (in press)
Shen CL, Yeh JK, Cao J, Wang J-S (2009) Green tea and bone metabolism. Nutr Res 29(7):437–456, Review
Weisburger JH (1999) Tea and health: the underlying mechanisms. Proc Soc Exp Biol Med 220(4):271–275, Review
Shen CL, Yeh JK, Stoecker BJ, Chyu MC, Wang JS (2009) Green tea polyphenols mitigate deterioration of bone microarchitecture in middle-aged female rats. Bone 44(4):684–690
Smith BJ, Lerner MR, Bu SY, Lucas EA, Hanas JS, Lightfoot SA, Postier RG, Bronze MS, Brackett DJ (2006) Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation. Bone 38(3):378–386
Wang JS, Luo H, Wang P, Tang L, Yu J, Huang T, Cox S, Gao W (2008) Validation of green tea polyphenol biomarkers in a phase II human intervention trial. Food Chem Toxicol 46(1):232–240
Shen CL, Wang P, Guerrieri J, Yeh JK, Wang JS (2008) Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporos Int 19(7):979–990
Villanueva AR, Mehr LA (1977) Modifications of the Goldner and Gomori one-step trichrome stains for plastic-embedded thin sections of bone. Am J Medica Tech 43:536–538
Parfitt AM, Drezner MJ, Glorieux FH, Kanis JA, Malluche H, Meunier PJ (1987) Bone histomorphometry: standardization of nomenclature, symbols and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595–610
Nielsen FH (2004) Dietary fat composition modifies the effect of boron on bone characteristics and plasma lipids in rats. BioFactors 20:161–171
Crenshaw TD, Peo ER, Lewis AJ Jr, Moser BD (1981) Bone strength as a trait for assessing mineralization in swine: a critical review of techniques involved. J Anim Sci 53:827–835
Nakagawa H, Wachi M, Woo JT, Kato M, Kasai S, Takahashi F, Lee IS, Nagai K (2002) Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochem Biophys Res Commun 292(1):94–101
Hafeez BB, Ahmed S, Wang N, Gupta S, Zhang A, Haqqi TM (2006) Green tea polyphenols induced apoptosis in human osteosarcoma SAOS-2 cells involves a caspase-dependent mechanism with downregulation of nuclear factor-kappaB. Toxicol Appl Pharmacol 216(1):11–19
Nakagawa H, Hasumi K, Takami M, Aida-Hyugaji S, Woo JT, Nagai K, Ishikawa T, Wachi M (2007) Identification of two biologically crucial hydroxyl groups of (-)-epigallocatechin gallate in osteoclast culture. Biochem Pharmacol 73(1):34–43
Yun JH, Pang EK, Kim CS, Yoo YJ, Cho KS, Chai JK, Kim CK, Choi SH (2009) Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts. J Periodontal Res 39(5):300–307
Takayanagi H, Kim S, Taniguchi T (2002) Signaling crosstalk between RANKL and interferons in osteoclast differentiation. Arthritis Res 4(Suppl 3):S227–S232, Review
Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH (2009) Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the NF-{kappa}B signal. Mol Pharmacol Oct 14 (in press)
Matsunaga K, Klein TW, Friedman H, Yamamoto Y (2002) In vitro therapeutic effect of epigallocatechin gallate on nicotine-induced impairment of resistance to Legionella pneumophila infection of established MH-S alveolar macrophages. J Infect Dis 185(2):229–236
Balga R, Wetterwald A, Portenier J, Dolder S, Mueller C, Hofstetter W (2006) Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro. Bone 39(2):325–335
Armour KJ, Armour KE, van’t Hof RJ, Reid DM, Wei XQ, Liew FY, Ralston SH (2001) Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis Rheum 44(12):2790–2796
Dumitrescu AL, Abd-El-Aleem S, Morales-Aza B, Donaldson LF (2004) A model of periodontitis in the rat: effect of lipopolysaccharide on bone resorption, osteoclast activity, and local peptidergic innervation. J Clin Periodontol 31(8):596–603
Droke EA, Hager KA, Lerner MR, Lightfoot SA, Stoecker BJ, Brackett DJ, Smith BJ (2007) Soy isoflavones avert chronic inflammation-induced bone loss and vascular disease. J Inflamm (Lond) 4:17
Acknowledgements
This study was supported by the Laura W. Bush Institute for Women’s Health and National Institutes of Health/National Center for Complementary and Alternative Medicine grant R21AT003735 (CLS) and the National Institutes of Health/National Cancer Institute grant CA90997 (JSW).
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shen, CL., Yeh, J.K., Samathanam, C. et al. Green tea polyphenols attenuate deterioration of bone microarchitecture in female rats with systemic chronic inflammation. Osteoporos Int 22, 327–337 (2011). https://doi.org/10.1007/s00198-010-1209-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-010-1209-2